A unique peptide deformylase platform to rationally design and challenge novel active compounds - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Scientific Reports Année : 2016

A unique peptide deformylase platform to rationally design and challenge novel active compounds

Alexis Denis
  • Fonction : Auteur

Résumé

Peptide deformylase (PDF) is considered an excellent target to develop antibiotics. We have performed an extensive characterization of a new PDF from the pathogen Streptococcus agalactiae, showing properties similar to other known PDFs. S. agalactiae PDF could be used as PDF prototype as it allowed to get complete sets of 3-dimensional, biophysical and kinetic data with virtually any inhibitor compound. Structure-activity relationship analysis with this single reference system allowed us to reveal distinct binding modes for different PDF inhibitors and the key role of a hydrogen bond in potentiating the interaction between ligand and target. We propose this protein as an irreplaceable tool, allowing easy and relevant fine comparisons between series, to design, challenge and validate novel series of inhibitors. As proof-of-concept, we report here the design and synthesis of effective specific bacterial PDF inhibitors of an oxadiazole series with potent antimicrobial activity against a multidrug resistant clinical isolate.
Fichier principal
Vignette du fichier
SFRAF.pdf (1.54 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01412212 , version 1 (08-12-2016)

Licence

Paternité

Identifiants

Citer

Sonia Fieulaine, Rodolphe Alves de Sousa, Laure Maigre, Karim Hamiche, Mickael Alimi, et al.. A unique peptide deformylase platform to rationally design and challenge novel active compounds. Scientific Reports, 2016, 6, ⟨10.1038/srep35429⟩. ⟨hal-01412212⟩
547 Consultations
117 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More